HI SCR45

Urges the Hawaii Department of Health to coordinate stockpiling a three-year supply of mifepristone, an oral medication used in approximately 63% of abortions in the United States.

Hawaii's Department of Health partnered with Kapiolani Medical Center for Women and Children in 2023 to maintain a one-year supply of mifepristone, which has a five-year shelf life.

An estimated 3,900 abortions occurred in Hawaii in 2024, with 64% sought by individuals under 30 years of age as of 2022.

In-person abortion care in Hawaii is currently only available on Maui and Oahu, limiting access for neighbor island residents.

Cites concerns about potential federal regulatory changes and supply chain disruptions for mifepristone following the 2022 Dobbs v. Jackson Women's Health Organization decision that overturned Roe v. Wade.